Ani Pharmaceuticals (ANIP) Non-cash Items (2012 - 2022)

Ani Pharmaceuticals has disclosed Non-cash Items across 8 years of filings, most recently posting $3.9 million for Q4 2022.

• Non-cash Items for Q4 2022 came in at $3.9 million, down 43.0% year-over-year; the trailing twelve-month figure through Dec 2022 was $3.9 million (down 43.0% YoY), and the FY2022 annual result was $3.9 million, up 531.0% from the prior year.
• Non-cash Items came in at $3.9 million for Q4 2022 at Ani Pharmaceuticals, down from $6.8 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $6.8 million in Q4 2021 to a low of $372000.0 in Q4 2020.
• The 5-year median for Non-cash Items is $3.9 million (2022), against an average of $4.0 million.
• Across the five-year window, Non-cash Items slumped 94.5% in 2020 and soared 1724.19% in 2021, its largest moves.
• Ani Pharmaceuticals' Non-cash Items stood at $2.2 million in 2018, then surged by 204.41% to $6.8 million in 2019, then plunged by 94.5% to $372000.0 in 2020, then jumped by 1724.19% to $6.8 million in 2021, then slumped by 43.0% to $3.9 million in 2022.
• The last three Non-cash Items figures came in at $3.9 million (Q4 2022), $6.8 million (Q4 2021), and $372000.0 (Q4 2020), per Business Quant data.